BiotechTube

Sample Collection

ApprovedRecruiting
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Infections, Bacterial

Conditions

Infections, Bacterial

Trial Timeline

Jan 1, 2027 → Dec 1, 2035

NCT ID
NCT02177721

About Sample Collection

Sample Collection is a approved stage product being developed by Emergent BioSolutions for Infections, Bacterial. The current trial status is recruiting. This product is registered under clinical trial identifier NCT02177721. Target conditions include Infections, Bacterial.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT02177721ApprovedRecruiting

Competing Products

20 competing products in Infections, Bacterial

See all competitors
ProductCompanyStageHype Score
AAVLP-HPV + Placebo2A PharmaPhase 1
25
VN-0200 + PlaceboDaiichi SankyoPhase 1
33
VN-0200Daiichi SankyoPhase 2
52
MicafunginAstellas PharmaPre-clinical
23
amphotericin B liposomal (Ambisome)Astellas PharmaApproved
85
Parenteral micafungin application + Other parenteral antifungal drugsAstellas PharmaPre-clinical
23
Ciclosporin and Mycophenolate-mofetil + Tacrolimus and Mycophenolate-mofetil + Tacrolimus and Mycophenolate-mofetil with change from Mycophenolate-mofetil to EverolimusAstellas PharmaApproved
85
MicafunginAstellas PharmaPre-clinical
23
MicafunginAstellas PharmaPhase 1
33
Micafungin + PlaceboAstellas PharmaPhase 3
77
Cefiderocol + Standard of CareShionogiPhase 2
52
Dolutegravir + Rlipivirine + GSK1265744ShionogiPhase 1
33
Xeruborbactam Oral Prodrug + CeftibutenShionogiPhase 1
33
Cefiderocol + Standard of CareShionogiPhase 2
52
Dolutegravir 50 mg twice daily + Dolutegravir placebo twice dailyShionogiPhase 3
77
Xeruborbactam Oral Prodrug + Ceftibuten + Xeruborbactam Oral Prodrug Placebo + Ceftibuten PlaceboShionogiPhase 1
33
Dolutegravir 50 mg tablet + Dolutegravir 50 mg oral granulesShionogiPhase 1
33
GW810781ShionogiPhase 2
52
GSK1349572 + Placebo + Iohexol Injection + Para-aminohippurate infusionShionogiPhase 1
33
CefiderocolShionogiPhase 2
52

Other Products from Emergent BioSolutions

Blood sample collectionApproved
77
AVA + Raxibacumab + DiphenhydramineApproved
77
Vaccination with ACAM2000Approved
77
AV7909 + BioThraxPhase 3
69
ACAM2000Phase 3
69